Evidence for kinase inhibitor activity in acute myeloid leukaemia
1 Pogledi
• 07/04/23
0
0
Ugraditi
administrator
Pretplatnici
Visit http://www.ecancer.org for more
Dr Ehninger (University Hospital Dresden, Dresden, Germany) talks to ecancertv at EHA 2015 about the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari